1. In subjects with normal renal function there was a strong positive correlation between serum concentrations of 25-hydroxycholecalciferol and 24,25-dihydroxycholecalciferol, as measured by competitive protein-binding assay.
Introduction
The metabolite of vitamin D,, 24R,25-dihydroxycholecalciferol* [24, ,D,l is produced by renal hydroxylation of the hepatic metabolite 25-hydroxycholecalciferol [25-(OH)D,] under conditions of vitamin D repletion in man (Mawer, 1978) and experimental animals (Boyle, Gray & DeLuca, 1971) . Its production seems to be regulated in a complex manner by parathyroid hormone, calcium, phosphorus and the other renal metabolite of 25-(OH)D,, 1,25-dihydroxycholecalciferol [ 1, , D,] (DeLuca, 1976; Tanaka, Lorenc & DeLuca, 1975) . Although the function of this metabolite is not yet clearly understood, recent studies in experimental animals (Holick, Baxter, Schraufrogel, Tavela & DeLuca, 1976) and man (Kanis, Cundy, Bartlett, Smith, Heynen, Warner & Russell, 1978) suggest that it may have distinctive biological actions of physiological and therapeutic importance. The kidney is most probably the major site of production of 24,25-(OH),D, but evidence for its production in gut (DeLuca & Schnoes, 1978) and cartilage tissue (Garabedian, Pezant, Corvol, Bailly du Bois & Balsan, 1976; Garabedian, Corvol, Bailly du Bois, Liberherr & Balsan, 1978) suggests that other sites of production may be biologically important.
In order to determine whether the kidney is indeed the major site of 24,25-(OH),D, production in man, we have utilized our recently described competitive protein-binding assay for 24,25-(OH),D, (Taylor, Hughes & de Silva, 1976) to measure serum 24,25-(OH),D, and 25-(OH)D, concentrations in normal subjects and anephric patients. In addition, the activity in vivo of the 24-hydroxylase system has been studied by measuring serum concentrations of labelled 24,25-(OH),D, in control and anephric subjects given an intravenous dose of radioisotopically labelled vitamin D,.
Materials and methods

Subjects
Nineteen subjects (eight men, 11 women) with normal renal function donated a blood sample for measurement of serum 25-(OH)D, and 24,25-(OH),D, concentrations. Blood from six anephric patients maintained on intermittent haemodialysis (Table 1) (Suda, DeLuca, Schnoes, Tanaka & Holick, 1970) , has been shown to be present in human serum (Mawer, 1978) .1 standard 24,25-(OH),D, or serum extract. A portion (1 -0 ml) of'the binding protein solution was added, and the contents of the tubes were mixed and incubated at O°C for 2 h. Dextran-coated charcoal (Murphy, 1967) , 0.2 ml, was added, and the samples were centrifuged and prepared for scintillation counting (Taylor et al., 1976) . Standard curves were constructed over the range 0.125-5.00 pmol (0.05-2-00 ng). The limit of detection of the assay was 0.25 pmol/ml of serum. D, and 25,26-(OH) ,D, was studied by using the method described above.
Methods
Serum samples from the subjects who received 3H,14C-labelled vitamin D, were extracted and chromatographed sequentially on columns of Sephadex LH20 eluted with chloroform/hexane (65 : 35, v/v) and chloroform/hexane (50 : 50, v/v) as previously described (Mawer et al., 1975) to separate labelled metabolites of vitamin D,. The radioactivity in each column fraction was counted in toluene-based scintillator with a Wallac-LKB Ultrobeta liquid-scintillation counter. Concentrations of radioactive metabolites were expressed as the percentage of the injected dose per litre of serum.
Results
The displacement of 25-[26,27-3H1(OH)D, from the rachitic rat serum binding-protein by 24,25-(OH),D, is shown in Fig. 1 When, however, similar measurements were made in anephric patients no such correlation existed, the serum 24,25-(OH),D, concentrations being much lower than expected from the correlation in normal subjects and in most instances undetectable (< 0.25 pmol/ml) ( Fig. 3 ; Table la; Table 2 ). Even when serum 25-(OH)D, concentrations were elevated after oral administration of 1 pmol (400 pg) of 25-(OH)D, there was no significant increase in serum 24,25-(OH),D, concentrations (Table 1, b and c) .
The results of the labelled vitamin D, metabolic study showed that, in contrast to the control subjects, anephric subjects produced no 24,25-(OH),D, ( Table 2 ). The precursor metabolite 25-(OH)D, was synthesized normally, as was the dihydroxylated metabolite 25,26-(OH),D, (Mawer et al., 1975) .
Synthesis of 1,25-(OH),D,, as estimated from relative loss of tritium at the l a position (Mawer, Backhouse, Taylor, Lumb & Stanbury, 1973) , was not observed in any of the subjects.
Discussion
The absence, or very low concentration, of 24,25-(OH),D, in the sera of anephric patients suggests that in man the kidney is the major site of production of this metabolite. This is in accordance with experimental observations in man and animals (Mawer, 1978; Boyle et al., 1971) . In contrast, Haddad, Min, Mendelsohn, Slatopolsky & Hahn (1977) recently reported significantly higher concentrations of 24,25-(OH),D, in normal subjects than we find (3-1-20.1 nmol/l). They detected 24,25-(OH),D, in the sera of eight anephric subjects (1.9-14.3 nmol/l).
The reason for these discrepancies is not entirely clear since the actual assay step used by both groups is very similar. The sample preparation procedure, however, differs somewhat in that our pre-assay chromatography is more extensive than theirs. It is possible therefore that one of the other hydroxylated metabolites of vitamin D,, such as 25-(OH) D, or 25, ,D,, may be measured by their method. Certainly both 25-(OH)D, and 25,26-(OH),D, interfere in the assay of 24,25-(OH),D, (Fig. 2) . This might explain not only the discrepancy in anephric patients but also why this group finds a higher concentration of 24,25-(OH),D, in normal subjects. As shown in Table 1 , trivial amounts of 24,25-(OH),D, were found in the sera of some of our anephric patients (1-2% serum 25-(OH)D, concentration). In all instances the amount detected was well below the 7.0 k 3.5% serum 25-(OH)D, concentration expected from the relationship between the two metabolites in subjects with normal renal function (Fig. 3) . This may represent 24,25-(OH),D, produced by extrarenal 24-hydroxylation of 25-(OH)D, or, more probably, a metabolite of vitamin D which interferes in the assay of 24,25-(OH),D,.
The pattern of metabolites produced from injected labelled vitamin D, has been shown to depend upon the vitamin D nutritional status of the subject (Mawer, 1978; Boyle et al., 1971 (Mawer et al., 1975) .
In the present study, the anephric subjects were deliberately dosed with vitamin D or 25-(OH)D, to ensure a degree of repletion that would normally result in 24-hydroxylase activity. Despite assayed concentrations of 25-(OH)D, above 25 nmol/l ( Table 1 and Table 2 ) no 24-hydroxylase activity or assayable 24,25-(OH),D, could be detected in the anephric patients. Production of this metabolite is also correlated in normal subjects with serum calcium and phosphorus concentrations (Mawer et al., 1975) . In two of the patients in the tracer study serum calcium measured immediately after dialysis was below the concentration at which 24-hydroxylase activity is normally observed. The significance of this relative hypocalcaemia is, however, difficult to assess since serum phosphorus concentration in all patients exceeded the minimum at which 24,25-(OH),D, is detected.
It has been suggested that extrarenal 24-hydroxylation of 25-(OH)D, occurs in anephric rats (Garabedian, Pavlovitch, Fellot & Balsan, 1974) , but very large doses of vitamin D, (625 nmol) were given to each animal and the significance of this finding when related to man on a normal vitamin D intake is questionable. 24-Hydroxylation of 25-(OH)D, has also been suggested in cartilage tissue in a system in vitro (Garabedian et al., 1976 (Garabedian et al., , 1978 , but again the relevance to man in vivo is unclear.
Thus our findings of undetectable or very low assayed concentrations of 24,25-(OH),D,, along with the failure to observe synthesis of labelled 24,25-(OH),D, in any of the vitamin D-replete anephric patients, suggest that in man the kidney is the major, if not only, site of 24-hydroxylation of 25- (0H)D , . TANAKA, Y., DELUCA, H.F., IKEKAWA, N., MORISAKI, 
